Back
FLC
Fluence Corporation Limited
π¦πΊ ASX
π UTILITIES
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
-13.74%
Annual Growth
5 years average annual capital growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
1
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Fluence Corp. Ltd. engages in the provision of fast-to-deploy, decentralized and smart water, and wastewater treatment solutions. The company is headquartered in Golden Valley, Minnesota. The company went IPO on 2007-12-18. The firm is engaged in wastewater treatment and reuse, high-strength wastewater treatment, wastewater-to-energy, industrial and drinking water markets, with its pre-engineered, standardized smart products solutions (SPS), including Aspiral, NIROBOX, SUBRE and Nitro. Its segments include Decentralized Municipal Water and Wastewater treatment (DMWW), Specialized Industrial Water solutions (SIW), High-Strength Wastewater and Waste-to-Energy (HSWW), SEA & China, Ivory Coast project (IVC), and Build-Own-Operate (BOO) projects and O&M contracts for equipment sales. The DMWW segment includes MABR (Aspiral, SUBRE and Nitro), and Nirobox products. The SIW segment focuses on water reuse applications and high-growth markets such as lithium mining, which supports the trend toward electrification. The HSWW segment is providing solutions that support the shift to global decarbonization.
π Performance
Price History
-79.67%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.06
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in FLC
1
π Total Capital Earnings
$2K
π Average investment frequency
37 weeks
π΅ Average investment amount
$922
β° Last time a customer invested in FLC
52 days
FLC investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
100%
πΆ Age of investors
18 - 25
26 - 34
35 - 90
100%
π Legal gender of investors
Female
100%
Male
Pearlers who invest in FLC also invest in...
Cleanaway Waste Management Ltd. engages in the provision of total waste management, industrial, and environmental services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2005-05-03. Its Solid Waste Services segment comprises the collection, recovery and disposal of all types of solid waste, including putrescible waste, inert waste, household waste and recovered waste. Its Industrial & Waste Services segment provides a variety of services to the resources, oil and gas, industrial and infrastructure markets. The services include high pressure cleaning, vacuum loading, pipeline maintenance, non-destructive digging, drain cleaning and CCTV. Its Liquid Waste & Health Services segment consists of Liquid Waste, which is engaged in the collection, treatment, processing, refining and recycling and destruction of hazardous and non-hazardous liquids, hydrocarbons and chemical waste, and others; and Health Services, which is engaged in the provision of services to the health sector for the safe treatment and disposal of health-related waste.
π Performance (5Yr p.a)
6.33%
π Share price
$2.87 AUD
ποΈ SOCIALLY AWARE
π¨ COMMERCIAL SERVICES & SUPPLIES
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
π Performance (5Yr p.a)
9.44%
π Share price
$36.07 AUD
π GLOBAL
π HIGH PRICE GROWTH
πΈ FINANCIALS
π€ TECHNOLOGY
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
π Performance (5Yr p.a)
12.18%
π Share price
$16.17 AUD
π GLOBAL
π€ TECHNOLOGY
β³οΈ DIVERSIFIED
π HIGH PRICE GROWTH
VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax
π Performance (5Yr p.a)
17.38%
π Share price
$108.60 AUD
π GLOBAL
π€ TECHNOLOGY
β³οΈ DIVERSIFIED
π HIGH PRICE GROWTH
CSL
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,398 full-time employees. The Companyβs areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Companyβs segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.
π Performance (5Yr p.a)
-0.76%
π Share price
$270.37 AUD
βοΈ HIGH GOVERNANCE
ποΈ SOCIALLY AWARE
𧬠BIOTECHNOLOGY
Want more shares? Try these...